| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
(1R,2S)-1-Amino-2-indanol is a catalytic ligand used in the preparation of a series of potent HIV-1 protease inhibitory peptides. It has also served as a chiral ligand in the catalytic asymmetric reduction of prochiral ketones with boranes. The compound is used to synthesize indinavir intermediates, which inhibit HIV-encoded protease.
|
|---|---|
| ln Vitro |
In vitro studies have shown that (1R,2S)-1-Amino-2-indanol is used to synthesize indinavir intermediates, which can inhibit HIV-encoded protease. The compound has also served as a chiral ligand in the catalytic asymmetric reduction of prochiral ketones. Its activity is assessed in terms of chiral induction and catalytic efficiency.
|
| ln Vivo |
No specific in vivo pharmacological activity data have been documented for (1R,2S)-1-Amino-2-indanol as a therapeutic agent. The compound is used as a chiral building block and catalytic ligand. It is not administered directly to animals. Its derivatives, including HIV protease inhibitors, may be evaluated in animal models.
|
| Enzyme Assay |
For non-cellular assays, (1R,2S)-1-Amino-2-indanol is characterized by standard analytical techniques including NMR, HPLC, and polarimetry to confirm identity, chemical purity, and enantiomeric purity. Purity: typically ≥99%. The compound has a molecular weight of 149.19 and molecular formula C₉H₁₁NO. Storage: room temperature in a cool and dark place (<15°C).
|
| Cell Assay |
For in vitro cell-based studies, (1R,2S)-1-Amino-2-indanol is not typically used as a direct test compound. It is a chiral building block for synthesizing biologically active molecules that are subsequently tested in cell-based assays. If handled in a biological laboratory context, standard safety precautions should be taken.
|
| Animal Protocol |
For in vivo animal studies, (1R,2S)-1-Amino-2-indanol is not administered directly as a test compound. It is used in chemical synthesis to produce pharmaceutical candidates, such as HIV protease inhibitors, that are subsequently evaluated in animal models. The compound can be formulated using standard injection vehicles if required.
|
| ADME/Pharmacokinetics |
(1R,2S)-1-Amino-2-indanol has a molecular weight of 149.19 and molecular formula C₉H₁₁NO. It appears as a white to light-yellow crystal powder. Solubility: soluble in methanol and water. Purity: typically ≥99%. Storage: room temperature in a cool and dark place (<15°C).
|
| Toxicity/Toxicokinetics |
(1R,2S)-1-Amino-2-indanol is for research use only and not for human consumption. Standard laboratory safety practices should be followed when handling this chemical. This chemical causes skin irritation and serious eye irritation. Appropriate personal protective equipment including gloves and safety glasses should be worn.
|
| Additional Infomation |
(1R,2S)-1-Amino-2-indanol (CAS 136030-00-7) is also known as (1R,2S)-(+)-1-amino-2-indanol. It is a catalytic ligand used in the preparation of HIV-1 protease inhibitory peptides. It has also served as a chiral ligand in the catalytic asymmetric reduction of prochiral ketones. No clinical trials or therapeutic approvals exist.
|
| Molecular Formula |
C9H11NO
|
|---|---|
| Molecular Weight |
149.19
|
| Exact Mass |
149.084
|
| CAS # |
136030-00-7
|
| PubChem CID |
2725045
|
| Appearance |
White to off-white solid powder
|
| Density |
1.2±0.1 g/cm3
|
| Boiling Point |
290.0±40.0 °C at 760 mmHg
|
| Melting Point |
117-121ºC
|
| Flash Point |
129.2±27.3 °C
|
| Vapour Pressure |
0.0±0.6 mmHg at 25°C
|
| Index of Refraction |
1.626
|
| LogP |
0.43
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
11
|
| Complexity |
149
|
| Defined Atom Stereocenter Count |
2
|
| SMILES |
C1=CC=C2C(=C1)C[C@@H]([C@@H]2N)O
|
| InChi Key |
LOPKSXMQWBYUOI-DTWKUNHWSA-N
|
| InChi Code |
InChI=1S/C9H11NO/c10-9-7-4-2-1-3-6(7)5-8(9)11/h1-4,8-9,11H,5,10H2/t8-,9+/m0/s1
|
| Chemical Name |
(1R,2S)-1-amino-2,3-dihydro-1H-inden-2-ol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: (1). This product requires protection from light (avoid light exposure) during transportation and storage. (2). Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: 100 mg/mL (670.29 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (16.76 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (16.76 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (16.76 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.7029 mL | 33.5143 mL | 67.0286 mL | |
| 5 mM | 1.3406 mL | 6.7029 mL | 13.4057 mL | |
| 10 mM | 0.6703 mL | 3.3514 mL | 6.7029 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
